Docket Navigator data shows the US District Court for the Eastern District of North Carolina, which oversees these high-profile litigations, has not handled many patent cases
The number of UPC actions filed in the first three months indicates that many rights holders are willing to engage with the new system, especially in Germany. As the court becomes more settled, the next 12 months could prove transformative for European patent litigation.
IAM Connect: Patent Policy and Litigation delved deeply into Section 101 legislation, reform efforts at the Patent Trial and Appeal Board, and reactions to the European Commission's SEP proposal
Planned change will make UPC more attractive to life sciences companies
28 April 2023
Various provisions in the USPTO’s rulemaking proposal favour patent owners and others lean towards petitioners, yet one thing is certain: chief IP officers must make their voices heard
26 April 2023
China’s Supreme Court’s IP branch has released its 2022 annual report, providing statistics on caseload and closure. These numbers highlight the longer wait times for appeals, as well as varying chances of success.
26 April 2023
Director Kathi Vidal’s proposed rules would expand discretionary denial into new categories, but heightened disclosure requirements might pain patentees and petitioners alike
21 April 2023
The Enlarged Board of Appeal's ruling in G2/21 has significant implications for the use of post-filed data
21 April 2023
With the European Commission increasingly ambivalent about patents, the UK has an opportunity to take leadership in areas such as SEP licensing and the life sciences
20 April 2023
His political savvy was on display as he leveraged a hot-button bipartisan issue – US competition with China – to highlight needed repairs to the US system
19 April 2023
In the US and Europe, immensely wealthy businesses that use technology created by others to drive their profits have succeeded in tilting the playing field in their favour
13 April 2023
The long-awaited G 2/21 decision is good news for applicants in the pharmaceutical space that have to rely on submitting experimental evidence generated or published after the application’s filing date.
06 April 2023
A fresh decision has highlighted that Greek courts dealing with patent cases should be precise and detailed when determining whether an invention meets the substantial patentability criteria set out in the law, and why.
05 April 2023
Unlock unlimited access to all IAM content
